Proposed Trans-Pacific Partnership Agreement—2014 Submission to DFAT

Submission Overview

As a strong advocate for free trade, the ECA supports the TPP negotiations, with the hope that they produce a high quality, comprehensive agreement. There are currently 12 parties negotiating the Agreement, including Japan, the United States, Singapore, New Zealand and Malaysia, which are five of Australia’s top ten trading partners according to ABS statistics. AIBS 2014 results reinforce the importance of these markets to Australian companies with respondents nominating the United States as the top current export market, while New Zealand came in third, Japan fifth, Singapore sixth and Malaysia eighth.

The ECA appreciates from the research done by DFAT that potential gains to Australian exporters and importers, (including SMEs) from a comprehensive TPP Agreement are significant. The current parties to the TPP negotiations cover 11.2 per cent of the world’s population and approximately 70 per cent of Australia's trade flows through the Asia-Pacific region. This, coupled with the fact that Australia does not have existing trade agreements with a number of the current TPP negotiating parties, highlights the opportunity for market access gains to be made.

Proposed Trans-Pacific Partnership Agreement—2014 Submission to DFAT

Download Submission Contact Us

Join Us

Become A Member

Ed Serrano
Managing Director,
VEKTA Advanced Automation
Member of the ECA

"In 2014 Vekta Automation became involved in the Export Awards and started to get a better understanding about the role of the Export Council of Australia. After attending a seminar in Perth in February 2019 the decision was instantly made and we signed up the next day. A decision we should have made 5 years earlier. For Vekta, the information, expertise and networking opportunities that the ECA provides has been valuable. It is reassuring knowing that there are experienced and knowledgeable people we can turn to when advice is needed."

Become a Member

Featured Member

Established in 1970, Mavlab Animal Health Pty Ltd is a Queensland based, family-owned, GMP licenced manufacturer of veterinary pharmaceuticals and pet care products. Mavlab has an extensive range of prescription and over the counter products sold in a growing number of global markets. Contract manufacturing opportunities are also available.